Overview

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
Study of Plitidepsin in combination with dexamethasone versus dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Phase:
Phase 3
Details
Lead Sponsor:
PharmaMar
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate